News

Chasing the diagnostic potential of RNA editing

Nathalie Gerassimov
Sept. 1, 2019

Nicholas O. Davidson wears many hats: He is a practicing physician, he is the division chief of gastroenterology at Washington University in St. Louis, and he holds professorships in medicine, developmental biology, and pharmacology and molecular biology. On top of that, he is the co-editor-in-chief of the Journal of Lipid Research and a principal investigator studying the genetic regulation of intestinal and hepatic lipid homeostasis, with authorship on more than 230 papers.

A recent paper by Davidson and colleagues, published in RNA Journal, deepens our understanding of tissue-specific regulation of programmed alteration of RNA, known as RNA editing, in the intestine and the liver.

“This paper identifies what we believe to be the complete machinery for a form of RNA editing,” Davidson said. “The approaches and the tools from this study can be applied to gain a better understanding of the function of most, if not all, types of mammalian cells.”

Davidson’s professional journey and scientific outlook was captured in ASBMB Today in a 2012 interview. In brief, his interest in gastroenterology emerged during his medical training at Kings College Hospital Medical School in London under the mentorship of Roger Williams, one of the trailblazers of liver transplantation. He further built his expertise by working with the late Pete Ahrens Jr. at The Rockefeller University in New York and during a gastroenterology fellowship at Columbia–Presbyterian Medical Center. His own lab started at the University of Chicago Medical Center before relocating to St. Louis. His research has helped shape the field of RNA editing over several decades.

The RNA editing team in the Davidson lab at Washington University in St. LouisThe RNA editing team in the Davidson lab at Washington University in St. Louis include, from left, Saeed Soleymanjahi, Nick Davidson and Valerie Blanc.Courtesy of Nick DavidsonRNA editing can create heterogeneity in genetically identical cells by mediating amino acid substitutions, alternative isoform creation and modification of stop codons. Furthermore, RNA editing in the 3’-untranslated region has been shown to be the alteration that most frequently leads to changes in RNA stability, RNA localization and protein translation. Advances in high-throughput sequencing techniques have shown that RNA-editing events are more pervasive than originally thought, prompting the introduction of the concept of an epitranscriptomic code to parallel the epigenetic code.

In 1994, Davidson’s team showed that one mechanism of RNA editing is the deamination of cytosine to uracil, which is catalyzed by the Apobec family, including Apobec-1. Other researchers later discovered that the Apobec-1 biochemical function requires a cofactor, and two different essential cofactors were discovered — Apobec-1 complementation factor, or A1cf, and RNA binding motif protein 47, or Rbm47.

Prior to this paper, the relative contribution of the two cofactors to physiological Apobec-1 function was not fully understood. Davidson’s team looked at the global RNA-editing landscape of mouse livers and intestines when either or both cofactors were deleted or were overexpressed as transgenes. Deletion of Rbm47, but not A1cf, caused a large, tissue-specific change in the RNA editing profile, with the intestines being most affected.

“The findings of this paper were somewhat surprising, since A1cf was discovered as necessary for the deaminase Apobec-1 to act on RNA, and it was originally thought to be the Apobec-1 cofactor,” Davidson said. “However, our data using a conditional tissue-specific deletion of Rbm47 alone or with A1cf point to Rbm47 as the dominant Apobec-1 cofactor in adult mouse liver and intestine.”

Davidson’s lab now is using the genetic tools from this study to illuminate further the role of RNA editing during development, where it is implicated in regulation of growth.

RNA-editing alterations also have been reported in cancers and neurological disorders, and Davidson’s lab is pursuing the profiling of DNA, RNA and protein levels in cancer tissues to substantiate further the diagnostic potential of RNA editing.

“This study fits into the emerging consensus in cancer biology that RNA editing can contribute to cancer susceptibility,” he said, “and this is a big direction that we are focusing on.”Apcmin/+ is a mouse model for tumorigenesis.Apcmin/+ is a mouse model for tumorigenesis. The top image shows a representative section of the intestine of an Apcmin/+ mouse. Arrows denote some of the many polyps. Deletion of the RNA-editing enzyme Apobec-1 in this model drastically reduces the number of polyps in the intestine. The Davidson lab is exploring how loss of cytosine to uracil RNA editing protects against intestinal tumorigenesis.Courtesy of Nick Davidson

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nathalie Gerassimov

Nathalie Gerassimov is a postdoctoral researcher at the Carnegie Institution of Washington department of embryology.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

 A new kind of stem cell is revolutionizing regenerative medicine
Feature

A new kind of stem cell is revolutionizing regenerative medicine

April 1, 2025

Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss and more. However, scientists still face hurdles such as strict regulations, scalability, cell longevity and immune rejection.

Engineering the future with synthetic biology
ASBMB Annual Meeting

Engineering the future with synthetic biology

March 31, 2025

Learn about the ASBMB 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance
Webinar

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance

March 28, 2025

Alejandro Vila, an ASBMB Breakthroughs speaker, discussed his work on metallo-β-lactamase enzymes and their dependence on zinc.

Host vs. pathogen and the molecular arms race
ASBMB Annual Meeting

Host vs. pathogen and the molecular arms race

March 28, 2025

Learn about the ASBMB 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.

Richard Silverman to speak at ASBMB 2025
ASBMB Annual Meeting

Richard Silverman to speak at ASBMB 2025

March 27, 2025

Richard Silverman and Melissa Moore are the featured speakers at the ASBMB annual meeting to be held April 12-15 in Chicago.

From the Journals: JBC
Journal News

From the Journals: JBC

March 25, 2025

How cells recover from stress. Cancer cells need cysteine to proliferate. Method to make small membrane proteins. Read about papers on these topics recently published in the Journal of Biological Chemistry.